Redox Regulation of Signal Transduction Mechanism in the Heart
心脏信号转导机制的氧化还原调节
基本信息
- 批准号:13470483
- 负责人:
- 金额:$ 9.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Reactive oxygen species (ROS) has been considered as an 'evil player' due to a strong reactivity. We have reported that trimeric G protein (G_i/G_0) is directly activated by one of ROS hydrogen peroxide (H_2O_2) in rat neonatal myocytes. Upon activation of G_i/G_0 by H_2O_2, Gβγis released from trimeric G_i/G_0 and the released Gβγ activates ERK to protect the cells against oxidative damage. We have now identified the amino acids that are modified by H_2O_2, and have found that the H_2O_2-mediated modification of cysteine residues located at 287 and 326 is necessary for activation of G_i. These results indicate that ROS can work as an intracellular mediator in the heart, and suggest that ROS generated by receptor stimulation can activate G_i and G_0. Other than the treatment of cells with H_2O_2, ROS was generated by receptor stimulation. Although angiotensin II stimulation generated ROS and induced MAP kinase activation, angiotensin II stimulation could not activate G_i and G_0. Therefore, we concluded that the amount of ROS is an important factor for activation of G protein. We have also found that the expression of peroxiredoxin II (PrxII) eliminates ROS from cells, and PrxII abolishes c-Jun NH_2-terminal kinase (JNK) activation without affecting ERK and p38 MAPK activation. It is concluded that angiotensin II activates specific signaling pathway leading to JNK activation. It also suggests that ROS can work as an intracellular mediator.
由于反应性强,活性氧(ROS)被认为是“邪恶的玩家”。我们已经报道说,三聚合物G蛋白(G_I/G_0)在大鼠新生儿心肌细胞中直接被一种ROS氢(H_2O_2)直接激活。 H_2O_2激活G_I/G_0后,从三聚体G_I/G_0释放的GβγIS和释放的Gβγ激活ERK,以保护细胞免受氧化损伤。现在,我们已经确定了由H_2O_2修饰的氨基酸,并发现位于287和326的半胱氨酸残留物的H_2O_2介导的修饰对于激活G_I是必需的。这些结果表明ROS可以作为心脏中的细胞内介体工作,并表明受体刺激产生的ROS可以激活G_I和G_0。除了用H_2O_2处理细胞外,通过受体刺激产生ROS。尽管血管紧张素II刺激产生了ROS并诱导MAP激酶激活,但血管紧张素II刺激无法激活G_I和G_0。因此,我们得出的结论是,ROS的量是激活G蛋白的重要因素。我们还发现,过氧蛋白II(PRXII)的表达消除了细胞中的ROS,而PRXII废除了C-JUN NH_2-末端激酶(JNK)激活而不会影响ERK和p38 MAPK激活。结论是,血管紧张素II激活了导致JNK激活的特定信号传导途径。这也表明ROS可以用作细胞内介体。
项目成果
期刊论文数量(49)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Endo, A. et al.: "Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII"J. Biol. Chem.. 277. 23747-23754 (2002)
Endo, A. 等人:“1-磷酸鞘氨醇通过血管内皮生长因子受体和 CrkII 诱导细胞膜褶皱并增加人脐静脉内皮细胞的运动性”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shiia, T., Nagao T. and Kurose H.: "Low affinity of β_i-adrenergic receptor for β-arrestins explains the resistance to agonist-induced internalization"Life Sci.. 68. 2251-2257 (2001)
Shiia, T.、Nagao T. 和 Kurose H.:“β_i-肾上腺素能受体对 β-arrestins 的低亲和力解释了对激动剂诱导内化的抵抗”Life Sci.. 68. 2251-2257 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Isogaya, M. et al.: "Enhanced cAMP response of the naturally occurring mutant of human β_3-adrenoceptor"Jpn. J. Pharmacol.. 88. 314-318 (2002)
Isogaya,M.等人:“人β_3-肾上腺素受体天然突变的增强的cAMP反应”Jpn. J. Pharmacol.. 88. 314-318 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arai K., Maruyama Y., Nishida Tanabe S., Takagahara S., Turner J. H., Kozasa T., Mori Y., Nagao T., and Kurose H.: "Differential requirement of Gα_<12>, Gα_<13>, Gα_q and Gβγ for endothelin-1-induced JNK and ERK activation"Mol. Pharmacol.. 63. 478-488 (20
Arai K.、Maruyama Y.、Nishida Tanabe S.、Takagahara S.、Turner J. H.、Kozasa T.、Mori Y.、Nagao T. 和 Kurose H.:“Gα_<12>、Gα_<13> 的差异要求、Gα_q 和 Gβγ 对于内皮素-1 诱导的 JNK 和 ERK 激活“Mol. Pharmacol.. 63. 478-488 (20
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Endo A., Nagashima K., Kurose H., Mochizuki S., Matsuda M., and Mochizuki N.: "Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII."J.
Endo A.、Nagashima K.、Kurose H.、Mochizuki S.、Matsuda M. 和 Mochizuki N.:“1-磷酸鞘氨醇通过血管内皮生长因子受体和 CrkII 诱导细胞膜褶皱并增加人脐静脉内皮细胞的运动性
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUROSE Hitoshi其他文献
KUROSE Hitoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUROSE Hitoshi', 18)}}的其他基金
Role of GRK in engulfment of apoptotic cells
GRK 在吞噬凋亡细胞中的作用
- 批准号:
23659043 - 财政年份:2011
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Roles of Voltage- and cation-independent TRPC channels in cardiac hypertrophy
电压和阳离子无关的 TRPC 通道在心脏肥大中的作用
- 批准号:
20390025 - 财政年份:2008
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The mechanism of G protein-mediated cardiac fibrosis
G蛋白介导的心肌纤维化机制
- 批准号:
18390028 - 财政年份:2006
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
mechanistic analysis of cardiac functions by building G protein signal network
通过构建G蛋白信号网络进行心脏功能机制分析
- 批准号:
17079007 - 财政年份:2005
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Establishment of a role of reactive oxygen species as a second messenger
活性氧作为第二信使的作用的确立
- 批准号:
15390027 - 财政年份:2003
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structural analysis and molecular modeling of high affinity binding and activation of β1-adrenergic receptor
β1-肾上腺素受体高亲和力结合和激活的结构分析和分子建模
- 批准号:
11672210 - 财政年份:1999
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
USP13去泛素化SIRT6抑制晶状体上皮细胞氧化应激的分子机制研究
- 批准号:82301192
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TFAM与LC3互作介导氧化应激下线粒体DNA的自噬降解机制
- 批准号:
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:
线粒体来源多肽MOTS-c通过PGC-1α-ROS轴抑制氧化应激在OA中的作用机制
- 批准号:82372446
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
circEP300/PIK3R3信号轴通过调控氧化应激及巨噬细胞M1型极化在草酸钙诱导的肾小管损伤及肾结石形成中的机制研究
- 批准号:82370769
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
环氧化物水解酶EPHX4通过c-Jun/NRF2在PCOS卵巢颗粒细胞氧化应激损伤中的作用机制研究
- 批准号:82301845
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 9.28万 - 项目类别:
Blood biomarkers to detect brain injury due to intimate partner violence
血液生物标志物可检测亲密伴侣暴力造成的脑损伤
- 批准号:
486950 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Operating Grants
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别: